Suven Pharma Consolidated December 2023 Net Sales at Rs 219.82 crore, down 37.86% Y-o-Y
February 08, 2024 / 13:57 IST
Reported Consolidated quarterly numbers for Suven Pharmaceuticals are: Net Sales at Rs 219.82 crore in December 2023 down 37.86% from Rs. 353.77 crore in December 2022. Quarterly Net Profit at Rs. 46.75 crore in December 2023 down 56.6% from Rs. 107.72 crore in December 2022. EBITDA stands at Rs. 79.49 crore in December 2023 down 50.23% from Rs. 159.71 crore in December 2022. Suven Pharma EPS has decreased to Rs. 1.84 in December 2023 from Rs. 4.23 in December 2022. Suven Pharma shares closed at 621.25 on February 07, 2024 (NSE) and has given 26.68% returns over the last 6 months and 27.16% over the last 12 months.
| Suven Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
Story continues below Advertisement
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 219.82 | 231.05 | 353.77 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 219.82 | 231.05 | 353.77 | | EXPENDITURE | | Consumption of Raw Materials | 63.53 | 51.16 | 136.04 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 8.91 | 6.45 | -26.40 | | Power & Fuel | -- | -- | -- | | Employees Cost | 32.83 | 28.58 | 29.68 | | Depreciation | 12.75 | 11.89 | 12.24 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | 2.27 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 49.40 | 46.91 | 65.49 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 52.39 | 86.07 | 134.46 | | Other Income | 14.34 | 19.84 | 13.01 | | P/L Before Int., Excpt. Items & Tax | 66.74 | 105.91 | 147.47 | | Interest | 1.27 | 0.50 | 1.38 | | P/L Before Exceptional Items & Tax | 65.47 | 105.41 | 146.08 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 65.47 | 105.41 | 146.08 | | Tax | 18.71 | 25.84 | 38.36 | | P/L After Tax from Ordinary Activities | 46.75 | 79.56 | 107.72 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 46.75 | 79.56 | 107.72 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 46.75 | 79.56 | 107.72 | | Equity Share Capital | 25.46 | 25.46 | 25.46 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.84 | 3.13 | 4.23 | | Diluted EPS | 1.84 | 3.13 | 4.23 | | EPS After Extra Ordinary | | Basic EPS | 1.84 | 3.13 | 4.23 | | Diluted EPS | 1.84 | 3.13 | 4.23 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
